5IFW image
Deposition Date 2016-02-26
Release Date 2016-10-26
Last Version Date 2024-01-10
Entry Detail
PDB ID:
5IFW
Title:
Quantitative interaction mapping reveals an extended ubiquitin regulatory domain in ASPL that disrupts functional p97 hexamers and induces cell death
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
3.40 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.23
Space Group:
C 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Tether containing UBX domain for GLUT4
Gene (Uniprot):ASPSCR1
Chain IDs:A
Chain Length:188
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Transitional endoplasmic reticulum ATPase
Gene (Uniprot):VCP
Chain IDs:B
Chain Length:807
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Quantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamers.
Nat Commun 7 13047 13047 (2016)
PMID: 27762274 DOI: 10.1038/ncomms13047

Abstact

Interaction mapping is a powerful strategy to elucidate the biological function of protein assemblies and their regulators. Here, we report the generation of a quantitative interaction network, directly linking 14 human proteins to the AAA+ ATPase p97, an essential hexameric protein with multiple cellular functions. We show that the high-affinity interacting protein ASPL efficiently promotes p97 hexamer disassembly, resulting in the formation of stable p97:ASPL heterotetramers. High-resolution structural and biochemical studies indicate that an extended UBX domain (eUBX) in ASPL is critical for p97 hexamer disassembly and facilitates the assembly of p97:ASPL heterotetramers. This spontaneous process is accompanied by a reorientation of the D2 ATPase domain in p97 and a loss of its activity. Finally, we demonstrate that overproduction of ASPL disrupts p97 hexamer function in ERAD and that engineered eUBX polypeptides can induce cell death, providing a rationale for developing anti-cancer polypeptide inhibitors that may target p97 activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures